These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 6402163)

  • 1. Long term correction of hyperglycaemia and progression of renal failure in insulin dependent diabetes.
    Viberti GC; Bilous RW; Mackintosh D; Bending JJ; Keen H
    Br Med J (Clin Res Ed); 1983 Feb; 286(6365):598-602. PubMed ID: 6402163
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of metabolic control on rate of decline in renal function in insulin-dependent diabetes mellitus with overt diabetic nephropathy.
    Mulec H; Blohmé G; Grände B; Björck S
    Nephrol Dial Transplant; 1998 Mar; 13(3):651-5. PubMed ID: 9550642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glycaemic control in diabetic nephropathy.
    Bending JJ; Pickup JC; Viberti GC; Keen H
    Br Med J (Clin Res Ed); 1984 Apr; 288(6425):1187-91. PubMed ID: 6424782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monitoring glomerular function in diabetic nephropathy. A prospective study.
    Viberti GC; Bilous RW; Mackintosh D; Keen H
    Am J Med; 1983 Feb; 74(2):256-64. PubMed ID: 6401924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of long-term near-normoglycemia on the progression of diabetic nephropathy.
    Ciavarella A; Vannini P; Flammini M; Bacci L; Forlani G; Borgnino LC
    Diabete Metab; 1985 Feb; 11(1):3-8. PubMed ID: 3884404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of 6 months of strict metabolic control on eye and kidney function in insulin-dependent diabetics with background retinopathy. Steno study group.
    Lancet; 1982 Jan; 1(8264):121-4. PubMed ID: 6119509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renal protection in diabetes--an emerging role for calcium antagonists.
    Parving HH; Tarnow L; Rossing P
    Cardiology; 1997; 88 Suppl 3():56-62. PubMed ID: 9397296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of continuous subcutaneous insulin infusion on renal function in type I diabetic patients with and without proteinuria.
    van Ballegooie E; de Jong PE; Donker AJ; Sluiter WJ
    Proc Eur Dial Transplant Assoc Eur Ren Assoc; 1985; 21():722-4. PubMed ID: 3991567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intermittent clinical proteinuria and renal function in diabetes: evolution and the effect of glycaemic control.
    Bending JJ; Viberti GC; Watkins PJ; Keen H
    Br Med J (Clin Res Ed); 1986 Jan; 292(6513):83-6. PubMed ID: 3080101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of strict glycemic control on renal hemodynamic response to amino acids and renal enlargement in insulin-dependent diabetes mellitus.
    Tuttle KR; Bruton JL; Perusek MC; Lancaster JL; Kopp DT; DeFronzo RA
    N Engl J Med; 1991 Jun; 324(23):1626-32. PubMed ID: 2030719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The natural history of diabetic nephropathy in type I diabetes and the role of metabolic control in its prevention, reversibility and clinical course.
    Wajchenberg BL; Sabbaga E; Fonseca JA
    Acta Diabetol Lat; 1983; 20(1):1-18. PubMed ID: 6344525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies of cardiovascular and renal function in subclinical and manifest diabetic nephropathy.
    Berglund J
    Acta Med Scand Suppl; 1988; 722():1-69. PubMed ID: 3163465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Predicting diabetic nephropathy].
    Mogensen CE; Christensen CK
    Journ Annu Diabetol Hotel Dieu; 1984; ():333-49. PubMed ID: 6399537
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of captopril on blood pressure and kidney function in normotensive insulin dependent diabetics with nephropathy.
    Parving HH; Hommel E; Damkjaer Nielsen M; Giese J
    BMJ; 1989 Aug; 299(6698):533-6. PubMed ID: 2507061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BP and Renal Outcomes in Diabetic Kidney Disease: The Veterans Affairs Nephropathy in Diabetes Trial.
    Leehey DJ; Zhang JH; Emanuele NV; Whaley-Connell A; Palevsky PM; Reilly RF; Guarino P; Fried LF;
    Clin J Am Soc Nephrol; 2015 Dec; 10(12):2159-69. PubMed ID: 26482258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. End-state renal failure in diabetic nephropathy: pathophysiology and treatment.
    Schmitz O; Hansen HE; Orskov H; Mogensen CE; Posborg Petersen V
    Blood Purif; 1985; 3(1-3):120-39. PubMed ID: 3913447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Irbesartan delays progression of nephropathy as measured by estimated glomerular filtration rate: post hoc analysis of the Irbesartan Diabetic Nephropathy Trial.
    Evans M; Bain SC; Hogan S; Bilous RW;
    Nephrol Dial Transplant; 2012 Jun; 27(6):2255-63. PubMed ID: 22172728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kidney function after improved metabolic control in newly diagnosed diabetes and in diabetic patients with nephropathy.
    Ciavarella A; Flammini M; Stefoni S; Borgnino LC; Forlani G; Bacci L; Vannini P
    Diabetes Care; 1982; 5(6):624-9. PubMed ID: 6927732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of antihypertensive therapy on kidney function in diabetic patients.
    Scherstén B
    Drugs; 1988; 35 Suppl 5():59-61. PubMed ID: 3063486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diabetic nephropathy. Clinical course in patients treated with the subcutaneous insulin pump.
    Cataland S; O'Dorisio TM
    JAMA; 1983 Apr; 249(15):2059-61. PubMed ID: 6339760
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.